UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Autism spectrum disorder: Diagnosis

Author
Marilyn Augustyn, MD
Section Editors
Marc C Patterson, MD, FRACP
Carolyn Bridgemohan, MD
Deputy Editor
Mary M Torchia, MD

INTRODUCTION

Autism spectrum disorder (ASD) is a biologically based neurodevelopmental disorder characterized by impairments in two major domains: 1) deficits in social communication and social interaction and 2) restricted repetitive patterns of behavior, interests, and activities [1]. ASD encompasses disorders previously known as autistic disorder (classic autism, sometimes called early infantile autism, childhood autism, or Kanner's autism), childhood disintegrative disorder, pervasive developmental disorder-not otherwise specified, and Asperger disorder (also known as Asperger syndrome). (See 'Diagnostic criteria' below and "Asperger syndrome (a specific autism spectrum disorder): Clinical features and diagnosis in children and adolescents" and "Asperger syndrome (a specific autism spectrum disorder): Management and prognosis in children and adolescents".)

The diagnosis of ASD will be reviewed here. Surveillance and screening for ASD and the terminology, epidemiology, pathogenesis, clinical features, and management of ASD are discussed separately. (See "Autism spectrum disorder: Surveillance and screening in primary care" and "Autism spectrum disorder: Terminology, epidemiology, and pathogenesis" and "Autism spectrum disorder: Clinical features" and "Autism spectrum disorder in children and adolescents: Overview of management".)

COMPREHENSIVE EVALUATION

Overview — Evaluation for ASD should include a comprehensive assessment, preferably by a team that has expertise in the diagnosis and management of ASD [2-7]. The evaluation should include a complete history, physical examination, neurologic examination, and direct assessment of the child's social, language, and cognitive development. Sufficient time should be set aside for standardized parent interviews regarding current concerns and behavioral history, as well as structured observation of social and communicative behavior and play. (See 'Diagnosis' below.)

The comprehensive evaluation has several objectives [5,8,9]:

Definitive diagnosis of ASD (see 'Diagnosis' below)

                               

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Nov 21 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. American Psychiatric Association. Autism spectrum disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, American Psychiatric Association, Arlington, VA 2013. p.50.
  2. Schopler E. On confusion in the diagnosis of autism. J Autism Child Schizophr 1978; 8:137.
  3. Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000; 55:468.
  4. Dover CJ, Le Couteur A. How to diagnose autism. Arch Dis Child 2007; 92:540.
  5. Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120:1183.
  6. Scottish Intercollegiate Guideline Network. Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders, a national clinical guideline, number 98. July 2007. www.sign.ac.uk/pdf/sign98.pdf (Accessed on February 08, 2011).
  7. National Institute for Health and Clinical Excellence. Autism. Recognition, referral and diagnosis of children and young people on the autism spectrum http://www.nice.org.uk/nicemedia/live/13572/56428/56428.pdf (Accessed on January 12, 2012).
  8. Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999; 29:439.
  9. Volkmar F, Siegel M, Woodbury-Smith M, et al. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2014; 53:237.
  10. Caronna EB, Augustyn M, Zuckerman B. Revisiting parental concerns in the age of autism spectrum disorders: the need to help parents in the face of uncertainty. Arch Pediatr Adolesc Med 2007; 161:406.
  11. Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 2009; 123:1383.
  12. Carey Temperament Scale. Harcourt Assessment. (harcourtassessment.com/haiweb/cultures/en-us/productdetail.htm?pid=015-8040-015).
  13. Chess S, Thomas A. Temperament in Clinical Practice, Guilford Press, New York 2005.
  14. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004; 113:e472.
  15. Teplin SW. Autism and related disorders. In: Developmental Behavioral Pediatrics, 3rd ed, Levine MD, Carey WB, Crocker AC (Eds), WB Saunders, Philadelphia 1999. p.589.
  16. Lainhart JE, Piven J, Wzorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997; 36:282.
  17. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003; 290:337.
  18. GeneReviews. PTEN hamartoma tumor syndrome (PHTS). Available at: ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=phts (Accessed on April 14, 2010).
  19. Fombonne E, Rogé B, Claverie J, et al. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999; 29:113.
  20. Sikora DM, Pettit-Kekel K, Penfield J, et al. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A 2006; 140:1511.
  21. Bukelis I, Porter FD, Zimmerman AW, Tierney E. Smith-Lemli-Opitz syndrome and autism spectrum disorder. Am J Psychiatry 2007; 164:1655.
  22. Stone WL, Lee EB, Ashford L, et al. Can autism be diagnosed accurately in children under 3 years? J Child Psychol Psychiatry 1999; 40:219.
  23. Volkmar FR, Klin A, Siegel B, et al. Field trial for autistic disorder in DSM-IV. Am J Psychiatry 1994; 151:1361.
  24. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. www.who.int/classifications/icd/en/bluebook.pdf (Accessed on June 04, 2013).
  25. Falkmer T, Anderson K, Falkmer M, Horlin C. Diagnostic procedures in autism spectrum disorders: a systematic literature review. Eur Child Adolesc Psychiatry 2013; 22:329.
  26. Krug DA, Arick J, Almond P. Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry 1980; 21:221.
  27. Gilliam JE. Gilliam Autism Rating Scale (GARS). Pro-Ed, Austin, TX 1995.
  28. Gilliam Autism Rating Scale, Third Edition (GARS-3). https://shop.acer.edu.au/acer-shop/group/GARS3 (Accessed on September 10, 2014).
  29. GARS-3: Gilliam Autism Rating Scale - Third Edition. Available at: www.proedinc.com/customer/productview.aspx?id=5818 (Accessed on September 10, 2014).
  30. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24:659.
  31. New York State Department of Health Early Intervention Program. Clinical practice guideline: The guideline technical report: Autism/Pervasive developmental disorders assessment and intervention for young children (age 0-3 years). Publication No. 4217, Albany, NY 1999.
  32. Rellini E, Tortolani D, Trillo S, et al. Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC) correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord 2004; 34:703.
  33. Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30:205.
  34. Autism Diagnostic Observation Schedule, Second Edition (ADOS-2). https://www.pearsonclinical.com.au/productdetails/502 (Accessed on February 06, 2013).
  35. Luyster R, Gotham K, Guthrie W, et al. The Autism Diagnostic Observation Schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J Autism Dev Disord 2009; 39:1305.
  36. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012; 61:1.
  37. Rivard M, Terroux A, Mercier C, Parent-Boursier C. Indicators of intellectual disabilities in young children with autism spectrum disorders. J Autism Dev Disord 2015; 45:127.
  38. American Psychiatric Association. Social (pragmatic) communication disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, American Psychiatric Association, Arlington, VA 2013. p.47.
  39. Stone WL, Lemanek KL, Fishel PT, et al. Play and imitation skills in the diagnosis of autism in young children. Pediatrics 1990; 86:267.
  40. Naughton AM, Maguire SA, Mann MK, et al. Emotional, behavioral, and developmental features indicative of neglect or emotional abuse in preschool children: a systematic review. JAMA Pediatr 2013; 167:769.
  41. Battaglia A, Carey JC. Etiologic yield of autistic spectrum disorders: a prospective study. Am J Med Genet C Semin Med Genet 2006; 142C:3.
  42. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86:749.
  43. Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med 2013; 15:399.
  44. Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med 2012; 366:733.
  45. Manning M, Hudgins L, Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12:742.
  46. Duncan AM, Chodirker B. Use of array genomic hybridization technology for constitutional genetic diagnosis in Canada. Paediatr Child Health 2011; 16:211.
  47. Beaudet AL. The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Dev 2013; 84:121.
  48. Agency for Healthcare Research and Quality. Genetic testing for developmental disabilities, intellectual disability, and autism spectrum disorder. http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=2095 (Accessed on September 08, 2015).
  49. Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010; 125:e727.
  50. Chudley AE, Gutierrez E, Jocelyn LJ, Chodirker BN. Outcomes of genetic evaluation in children with pervasive developmental disorder. J Dev Behav Pediatr 1998; 19:321.
  51. Skjeldal OH, Sponheim E, Ganes T, et al. Childhood autism: the need for physical investigations. Brain Dev 1998; 20:227.
  52. Simonoff E. Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord 1998; 28:447.
  53. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369:1502.
  54. Tammimies K, Marshall CR, Walker S, et al. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. JAMA 2015; 314:895.
  55. Miles JH. Complex Autism Spectrum Disorders and Cutting-Edge Molecular Diagnostic Tests. JAMA 2015; 314:879.
  56. Sanmann JN, Schaefer GB, Buehler BA, Sanger WG. Algorithmic approach for methyl-CpG binding protein 2 (MECP2) gene testing in patients with neurodevelopmental disabilities. J Child Neurol 2012; 27:346.
  57. Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. J Child Neurol 2008; 23:307.
  58. Weissman JR, Kelley RI, Bauman ML, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One 2008; 3:e3815.
  59. Schiff M, Benoist JF, Aïssaoui S, et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One 2011; 6:e21932.
  60. Campistol J, Díez-Juan M, Callejón L, et al. Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders. Dev Med Child Neurol 2016; 58:842.
  61. Cooper AS, Friedlaender E, Levy SE, et al. The Implications of Brain MRI in Autism Spectrum Disorder. J Child Neurol 2016; 31:1611.
  62. Hughes R, Poon WY, Harvey AS. Limited role for routine EEG in the assessment of staring in children with autism spectrum disorder. Arch Dis Child 2015; 100:30.